激素替代治疗与卵巢癌关系的研究进展

[1] Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer[J] . Sujata S. Ohri,Aruna Vashishta,Mary Proctor,Martin Fusek,Vaclav Vetvicka.Cancer Biology ＆ Therapy . 2007 (7)

[2] Effects of progesterone and anti-progestin （mifepristone） treatmenton proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3[J] . Raffaèle Fauvet,Charlotte Etienne,Christophe Poncelet,Annie-France Bringuier,Gérard Feldmann,Emile Dara?.Oncology Reports . 2006 (4)

[3] Overexpression of the human tissue kallikrein genes KLK4 , 5 , 6 , and 7 increases the malignant phenotype of ovarian cancer cells[J] . Panagiotis Prezas,Matthias J.E. Arlt,Petar Viktorov,Antoninus Soosaipillai,Leon Holzscheiter,Manfred Schmitt,Maroulio Talieri,Eleftherios P. Diamandis,Achim Krüger,Viktor Magdolen.Biological Chemistry . 2006 (6)

[4] Potential markers that complement expression of CA125 in epithelial ovarian cancer [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 267 - 277

[5] Ovarian cancer patients and hormone replacement therapy: a systematic review[J] . M.L Hopkins,M Fung Kee Fung,T Le,R Shorr.Gynecologic Oncology . 2004 (3)

[6] Inhibitory Effects of 17β-Estradiol and Progesterone on Ovarian Carcinoma Cell Proliferation: A Potential Role for Inducible Nitric Oxide Synthase[J] . Marta Keith Bechtel,Benjamin Bonavida.Gynecologic Oncology . 2001 (1)

[7] Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival[J] . Menopause . 2001 (1)

[8] Current perspectives on the benefits of HRT in menopausal women[J] . S Palacios.Maturitas . 1999

[9] HORMONE REPLACEMENT THERAPY AND SURVIVAL AFTER SURGERY FOR OVARIAN-CANCER [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6771) : 259 - 262

[1] Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer[J] . Sujata S. Ohri,Aruna Vashishta,Mary Proctor,Martin Fusek,Vaclav Vetvicka.Cancer Biology ＆ Therapy . 2007 (7)

[2] Effects of progesterone and anti-progestin （mifepristone） treatmenton proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3[J] . Raffaèle Fauvet,Charlotte Etienne,Christophe Poncelet,Annie-France Bringuier,Gérard Feldmann,Emile Dara?.Oncology Reports . 2006 (4)

[3] Overexpression of the human tissue kallikrein genes KLK4 , 5 , 6 , and 7 increases the malignant phenotype of ovarian cancer cells[J] . Panagiotis Prezas,Matthias J.E. Arlt,Petar Viktorov,Antoninus Soosaipillai,Leon Holzscheiter,Manfred Schmitt,Maroulio Talieri,Eleftherios P. Diamandis,Achim Krüger,Viktor Magdolen.Biological Chemistry . 2006 (6)

[4] Potential markers that complement expression of CA125 in epithelial ovarian cancer [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 267 - 277

[5] Ovarian cancer patients and hormone replacement therapy: a systematic review[J] . M.L Hopkins,M Fung Kee Fung,T Le,R Shorr.Gynecologic Oncology . 2004 (3)

[6] Inhibitory Effects of 17β-Estradiol and Progesterone on Ovarian Carcinoma Cell Proliferation: A Potential Role for Inducible Nitric Oxide Synthase[J] . Marta Keith Bechtel,Benjamin Bonavida.Gynecologic Oncology . 2001 (1)

[7] Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival[J] . Menopause . 2001 (1)

[8] Current perspectives on the benefits of HRT in menopausal women[J] . S Palacios.Maturitas . 1999

[9] HORMONE REPLACEMENT THERAPY AND SURVIVAL AFTER SURGERY FOR OVARIAN-CANCER [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6771) : 259 - 262